BIT 1.45% 6.8¢ biotron limited

No mention of Biotron or its compound anywhere including the...

  1. 16,246 Posts.
    lightbulb Created with Sketch. 742
    No mention of Biotron or its compound anywhere including the CSIRO covid-19 website. CSIRO is all go for a vaccibe.



    CSIRO BEGINS TESTING COVID-19 VACCINES

    CSIRO, Australia’s national science agency, has commenced the first stage of testing potential vaccines for COVID-19. The testing, expected to take three months, is underway at CSIRO’s high-containment biosecurity facility, the Australian Animal Health Laboratory (AAHL) in Geelong.

    To prepare for disease outbreaks, last year CSIRO partnered with the Coalition for Epidemic Preparedness Innovations (CEPI), a global group that aims to derail epidemics by speeding up the development of vaccines.

    In January, CEPIengaged CSIROto start working on the virus SARS CoV-2, which causes the disease COVID-19. In consultation with the World Health Organisation, CEPI has identified vaccine candidates fromThe University of Oxford(UK) andInovio Pharmaceuticals Inc. (US) to undergo the first pre-clinical trials at CSIRO, with further candidates likely to follow.

    The latest milestone builds on CSIRO’s growing work to tackle COVID-19, which has included scaling up other potential vaccine candidates at its biologics production facility in Melbourne.




    CSIRO’s COVID-19 research so far

    Current rapid work on COVID-19 spans virus and vaccine:

    • CSIRO was the first research organisation outside of China to generate sufficient stock of the virus —using the virus strain isolated by the Doherty Institute — to enable pre-clinical studies and research on COVID-19.
    • CSIRO successfullyestablished a biological modelin February 2020, the first in the world to confirm ferrets react to SARS-CoV-2 (the virus that causes COVID-19). Researchers have quickly progressed to studying the course of infection in the animals – a crucial step in understanding if a vaccine will work.
    • CSIRO researchers confirmed, after studying SARS CoV-2’s genomic sequence that the virus is presently changing into a number of distinct ‘clusters’ and are now starting to look at how this may also impact on the development of a vaccine.

    For more information on CSIRO’s COVID-19 work, visit:www.csiro.au/COVID-19



    Last edited by malmanu: 02/04/20
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
6.8¢
Change
-0.001(1.45%)
Mkt cap ! $61.35M
Open High Low Value Volume
6.9¢ 6.9¢ 6.8¢ $56.43K 828.1K

Buyers (Bids)

No. Vol. Price($)
2 456468 6.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.3¢ 61089 3
View Market Depth
Last trade - 16.10pm 25/04/2024 (20 minute delay) ?
Last
6.8¢
  Change
-0.001 ( 1.45 %)
Open High Low Volume
6.9¢ 6.9¢ 6.8¢ 143438
Last updated 15.59pm 25/04/2024 ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.